Different response to rituximab in tumor necrosis factor blocker–naive patients with active ankylosing spondylitis and in patients in whom tumor necrosis factor blockers have failed: A twenty‐four–week clinical trial
Year: 2010
Type: article
Study design: Clinical Trial
Source: Arthritis & Rheumatism
DOI: 10.1002/art.27383
Language: English
Subfield: Rheumatology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W1997764596
